I really believe that they will be acquired before
Post# of 405
(Total Views: 2541)
Posted On: 05/13/2017 11:44:36 PM
I really believe that they will be acquired before a rs ever takes place. I still say by end of June 2019, a buyout will happen. We just doubled our annual revenue for 2018 with the Hikma deal.
Hikma seems to be interested in getting a stronghold on all Flonase generics...they scooped up Roxane Labs in March 2016 for Billions - they sure could grab INNV for a few hundred million. FlutiCare = 3rd NATIONAL BRAND
* Shareholders need to apply pressure on Bassam in a good way - email/call him repeatedly and let him know (remind him) about dilution and keeping costs down. Part of his salary is to answer to us. We are also part owners folks and need to ensure the Profitability goal is MET. I sincerely hope this does go down in price because intelligent investors/newbies will see a bargain basement opportunity. Way more near-term UPSIDE IMO
Whomever bought that offering is convinced we will be OVER 15 cents. THINK folks...we're trading 11 cents now. Let it go on sale, PLEASE
I have never been more confident as Fluti is our backstop and other (BH) Revs are increasing over 25% qtr over qtr.
Hikma seems to be interested in getting a stronghold on all Flonase generics...they scooped up Roxane Labs in March 2016 for Billions - they sure could grab INNV for a few hundred million. FlutiCare = 3rd NATIONAL BRAND
* Shareholders need to apply pressure on Bassam in a good way - email/call him repeatedly and let him know (remind him) about dilution and keeping costs down. Part of his salary is to answer to us. We are also part owners folks and need to ensure the Profitability goal is MET. I sincerely hope this does go down in price because intelligent investors/newbies will see a bargain basement opportunity. Way more near-term UPSIDE IMO
Whomever bought that offering is convinced we will be OVER 15 cents. THINK folks...we're trading 11 cents now. Let it go on sale, PLEASE
I have never been more confident as Fluti is our backstop and other (BH) Revs are increasing over 25% qtr over qtr.
(1)
(0)Innovus Pharmaceuticals Inc. (INNV) Stock Research Links
Scroll down for more posts ▼